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“Around the Globe,” in which the level of availability,
fruition, and improvement in radiation oncology is
described by radiation oncologists in each country. Within
this symbolic tour was a published report from Israel that
caught our attention (1). In that report, we read that: “Today,
Israel’s population exceeds 8 million and is composed of
75% Jews and 25% non-Jews, mostly Arab.” Furthermore,
“[a]ccording to Israel National Cancer Registry data, in
2013, malignant disease was diagnosed in nearly 30,000
citizens. Approximately 45%, or 14,000 patients, received
some form of radiation treatment.”
If this incidence (1/266 inhabitants annually) is compared
with the Italian incidence (1/161) (2), one sees that the
incidence in Israel is lower than that in Europe.
Corn et al (1) also reported that in 8 hospitals equipped
with radiation therapy, 24 linear accelerators were working,
for a ratio of about 1 accelerator per 300,000 inhabitants,
which is not far from the European standard (1/200,000).
Thus, considering the lower incidence of cancer in Israel,
the available equipment ensures a high level of care.
Recently, we studied cancer mortality and the avail-
ability of oncologic equipment in the West Bank, where no
radiation oncology machines are available, despite a resi-
dent population of 4.5 million (3). In East Jerusalem, 2
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Authority is building an oncology hospital, but it has not
yet been established whether it will provide, or will be
allowed to provide, radiation therapy.
Access to cancer treatment in developing countries,
where the cancer burden is high and the drugs are expensive
and paid for privately, is greatly needed (4). The availability
of basic cancer treatment services, including surgery,
chemotherapy, and radiation therapy, along with a clear
referral system for these services, is crucial to building a
comprehensive cancer service (5). Radiation therapy for
cancer patients is limited and inaccessible in middle- and
low-income countries, respectively, although desperately
needed, especially when cancer is diagnosed at advanced
stages, as happens in these countries. Radiation therapy is
the most cost-effective treatment for curative and palliative
cancer care, especially when combined with surgery (6).
In addition to the availability of cancer services, the
published data have referred to the relationship between
hospital volume and patient outcomes for cancer surgery. It
has been shown that a greater hospital volume improves
cancer surgery outcomes, in particular for lung and pancre-
atic surgery (7). In a review, Hillner et al (8) observed a
positive relationship between hospital volume and cancer
patient outcomes at initial cancer treatment for technologi-
cally complex surgical procedures, such as intra-abdominal,Conflict of interest: none.
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the availability of cancer-specific technologies has not been
associated with greater health care spending compared with
other technologies (9).
In Palestine, 3 main oncology services are available in
the West Bank: 2 governmental hospitals (Beit Jala Hos-
pital in Bethlehem and al-Watani Hospital in Nablus) and 1
nongovernmental hospital in East Jerusalem (Augusta
Victoria). In addition, 2 governmental hospitals, in Jenin
and Tulkarm, have recently started to provide oncology
services. Cancer patients are offered free treatment through
their government health insurance, with a small charge for
some drugs during cancer treatment. Cancer patients are
given referrals to services in East Jerusalem, Jordan, Egypt,
and other countries. Of the Palestinian Ministry of Health
referrals for services outside of the West Bank, 13.5% are
for patients with malignant tumors (10).
Our mortality study in the West Bank showed age-
standardized ratios of 80/10,000 inhabitants for men and
50/100,000 for women, about one half the ratios found for
Italy. Thus, the need for radiation therapy machines might
be 1 for 400,000 inhabitants (11).
We know that large differences exist worldwide with
regard to radiation oncology availability, mostly because of
technological maintenance difficulties in some areas. Some
have argued that installing 60Co teletherapy is unsafe because
of the danger of the technology being used for terrorist
purposes. This has never happened; however, this unfounded
argument has resulted in delayed implementation (12).
Very recently, an overview of radiation therapy world-
wide showed that the costs, including the investment and
operational costs and costs per treatment, vary substantially
by geographic region. These cost data are also reflected in
the gaps in radiation treatment options and associated re-
sources available across different regions.
The actual coverage of cancer care needs ranges from
34% in Africa to >92% in Europe to about double that in
North America. Thus, the proportional additional in-
vestments and operational costs will be as great as >200%
in Africa to almost none in North America (13).
Surprisingly, the report by Corn et al (1) regarding the
radiation therapy facilities did not report on the situation in
the West Bank or Palestine. Furthermore, differences exist
in international recognition of that area. Regardless, med-
ical doctors are interested in people, without regard to race,
religion, sex, and political differences.
It is more than just a money shortage that prevents the
introduction of isotopic machines into the West Bank. Themilitary occupation and the daily obstacles that preventing
patients from freely moving about also affect cancer care
outcomes.
Although financial investment in technology is unde-
niably necessary, many deaths from untreated cancer in
low- and median-income countries also occur for political
reasons in the form of the deliberate denial of access to
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